Floatz logo

Velpatasvir

Iatrogenic Disease

Alexandria UniversitySmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Iatrogenic Disease cohort.

Asset / SponsorPhaseRating
AUTOLOGOUS CONDITIONED PLASMA
Star Spine and Sport
Phase 4BB
Sofosbuvir
Alexandria University
Phase 4BB
NEPENTHE
Tiva Group
Phase 4BB
NADROPARIN
Rijnstate Hospital
Phase 4BB
Paliperidone
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Phase 4BB

View all 36 →

Same molecule, other indications

Velpatasvir is also rated in:

hepatitis C virus infectionActive
A
Indicative · Phase 4
84 / 100
View asset →
chronic hepatitis C virus infectionDormant
BB
Indicative · Phase 4
65 / 100
View asset →
chronic hepatitis B virus infectionDormant
BB
Indicative · Phase 4
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →